BioViva USA
PrivateLast Round
Series A
Nov 11, 2022
Total Funding Raised
$250,000
Company Overview
BioViva USA is a biotechnology company that develops gene therapy platforms to treat severe genetic disorders and address the root causes of cellular aging.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Healthcare Analytics, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BioViva USA Comparables
Compare BioViva USA with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Unlimited Bio | 79% | |
| YouthBio Therapeutics | 78% | |
| Turn Biotechnologies | 77% |
BioViva USA Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Nov 11, 2022 | ||||
| Early Funding | Apr 1, 2016 | ||||
| Seed | May 27, 2015 |
BioViva USA Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Deep Knowledge Life Sciences | Early Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 1, 2016
Raised funding with participation from Deep Knowledge Life Sciences.
- May 27, 2015
$250K raised in Seed round.
BioViva USA Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about BioViva USA's valuation, stock price, and market status.
Is BioViva USA a public or private company?
BioViva USA is a private company.
What is the current stock price of BioViva USA?
BioViva USA is a private company with no public stock price. No recent secondary market data is available.
How much is BioViva USA worth (valuation)?
Valuation information for BioViva USA is not publicly available.
Can I buy BioViva USA stock?
BioViva USA shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was BioViva USA's last funding round?
BioViva USA's most recent funding round was Series A on November 11, 2022.
Who are the main investors in BioViva USA?
Key investors in BioViva USA include Deep Knowledge Life Sciences.
Will BioViva USA IPO soon?
No public IPO plans have been announced for BioViva USA.
How can I track BioViva USA secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor BioViva USA's secondary market activity and sign up for updates.